An open, randomized, comparative clinical and histological study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum

Annals of Dermatology

Volumn 22, Issue 2, 2010, Pages 156-162

  Seo, Sang Hee ^a   Chin, Hyun Woo ^a   Jeong, Dong Wook ^a   Sung, Hyun Woo ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Dong A University   (South Korea)

Author keywords

Imiquimod; Molluscum contagiosum; Potassium hydroxide

Indexed keywords

EID: 77954695970     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2010.22.2.156     Document Type: Article

References (16)

1. Grayson W, Calonge E, McKee PH. Infectious diseases of the skin. In: McKee PH, Calonje E, Granter SR, editors. Pathology of the skin: with clinical correlations. 3rd ed. Philadelphia: Elsevier Mosby, 2005: 838-992.
2. Scheinfeld N. Treatment of molluscum contagiosum: a brief review and discussion of a case successfully treated with adapelene. Dermatol Online J 2007;13: 15. (Pubitemid 47117713)
3. Callen JP. Immunomodulators. In: Callen JP, Horn TH, Mancini AJ, editors. Dermatology. 2nd ed. Philadelphia: Mosby Elsevier, 2008: 1974-1989.
4. Romiti R, Ribeiro AP, Grinblat BM, Rivitti EA, Romiti N. Treatment of molluscum contagiosum with potassium hydroxide: a clinical approach in 35 children. Pediatr Dermatol 1999;16: 228-231. (Pubitemid 29270212)
5. Gould D. An overview of molluscum contagiosum: a viral skin condition. Nurs Stand 2008;22: 45-48.
6. Roberts S. Warts and molluscum: an impractical guide. Arch Dis Child Educ Pract Ed 2007;92: 199-200.
7. Simonart T, De Maertelaer V. Curettage treatment for molluscum contagiosum: a follow-up survey study. Br J Dermatol 2008;159: 1144-1147.
8. Bayerl C, Feller G, Goerdt S. Experience in treating molluscum contagiosum in children with imiquimod 5% cream. BrJ Dermatol 2003;149(Suppl 66): 25-29. (Pubitemid 38064510)
9. Cathcart S, Coloe J, Morrell DS. Parental satisfaction, efficacy, and adverse events in 54 patients treated with cantharidin for molluscum contagiosum infection. Clin Pediatr (Phila) 2009;48: 161-165.
10. Barba AR, Kapoor S, Berman B. An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children. Dermatol Online J 2001; 7: 20. (Pubitemid 38956775)
11. Theos AU, Cummins R, Silverberg NB, Palier AS. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis 2004;74: 134-138, 141-142. (Pubitemid 39207747)
12. Romiti R, Ribeiro AP, Romiti N. Evaluation of the effectiveness of 5% potassium hydroxide for the treatment of molluscum contagiosum. Pediatr Dermatol 2000;17: 495. (Pubitemid 32039323)
13. Metkar A, Pande S, Khopkar U. An open, nonrandomized, comparative study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Indian J Dermatol Venereol Leprol 2008;74: 614-618.
14. Arany I, Tyring SK. Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions. J Interferon Cytokine Res 1996; 16: 453-460. (Pubitemid 26391571)
15. Schneider-Schaulies S, Dittmer U. Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression. J Gen Virol 2006;87: 1423-1438. (Pubitemid 43827197)
16. Wainberg MA, Mills EL. Mechanisms of virus-induced immune suppression. Can Med Assoc J 1985;132: 1261-1267.